Komori
Revision to earnings forecast7600Japan Medical Dynamic Marketing,INC.Electrical and Precision Instruments

Notice concerning the difference between the forecast and actual consolidated results for the second quarter of the fiscal year ending March 2027, revisions to the full-year consolidated earnings forecast, recognition of adjustments to corporate income taxes and other items, and revisions to the dividend forecast

For the second quarter of the fiscal year ending March 2027, net sales and each profit measure fell below the previous forecasts, resulting in a net loss. Accordingly, the full-year forecasts for net sales and each profit measure were revised significantly downward, and the year-end dividend forecast was changed from ¥17 to no dividend.

Worth reading
80Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-14.5
%
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Six months and full yearPrevious forecast published 8 May 2026
Net SalesCumulative second-quarter results11,670→10,437million
-10.6%
Net SalesFull year25,370→21,700million
-14.5%
Operating profitCumulative second-quarter results-260→-1,036million
-298.5%
Operating profitFull year430→-1,500million
-448.8%
Ordinary incomeCumulative second-quarter results-410→-1,161million
-183.2%
Ordinary incomeFull year140→-1,750million
-1,350.0%
Profit attributable to owners of the parentCumulative second-quarter results-330→-1,749million
-430.0%
Profit attributable to owners of the parentFull year60→-2,500million
-4,266.7%
Net income per shareCumulative second-quarter results-12.53→-66.39yen
-429.8%
Net income per shareFull year2.28→-94.86yen
-4,260.5%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

In Japan, business opportunities in the artificial joint market declined, and there were instances in which the adoption of products was deferred. In the United States, transactions with some existing customers are expected to decline, along with the competitiveness of existing products, and the launch of new products is expected to be delayed. On the profit side, the company expects lower sales, a higher burden of fixed manufacturing costs accompanying lower production volumes, and higher import procurement costs due to the weaker yen. In addition, the forecast incorporates an adjustment to corporate income taxes of ¥629 million due to the reversal of deferred tax assets and one-time expenses of approximately ¥280 million, including retirement-related costs.

Details and amount of extraordinary loss

An adjustment to corporate income taxes of ¥629 million accompanying the reversal of deferred tax assets, and one-time expenses of approximately ¥280 million, including retirement-related costs.

Previous-period resultsSecond quarter of the fiscal year ending March 2026: net sales of ¥11,610 million, operating profit of ¥208 million, ordinary profit of ¥130 million, interim net income attributable to owners of the parent of ¥69 million, and interim earnings per share of ¥2.65. Full year of the fiscal year ending March 2026: net sales of ¥23,917 million, operating profit of ¥574 million, ordinary profit of ¥534 million, net income attributable to owners of the parent of ¥263 million, and earnings per share of ¥9.99.
Dividend forecast revisionThe dividend at the end of the second quarter remains ¥0, unchanged. The year-end dividend forecast was changed from ¥17 to ¥0, and the annual dividend forecast was changed from ¥17 to ¥0.
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net SalesCumulative second-quarter results 11,670 / Full year 25,370 → Cumulative second-quarter results 10,437 / Full year 21,700(Cumulative second-quarter results △10.6% / Full year △14.5%)
Operating profitCumulative second-quarter results -260 / Full year 430 → Cumulative second-quarter results -1,036 / Full year -1,500
Ordinary incomeCumulative second-quarter results -410 / Full year 140 → Cumulative second-quarter results -1,161 / Full year -1,750
Profit attributable to owners of the parentCumulative second-quarter results -330 / Full year 60 → Cumulative second-quarter results -1,749 / Full year -2,500
Net income per shareCumulative second-quarter results -12.53 / Full year 2.28 → Cumulative second-quarter results -66.39 / Full year -94.86
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredSix months and full year
Publication date of previous forecast8 May 2026
Previous-period resultsSecond quarter of the fiscal year ending March 2026: net sales of ¥11,610 million, operating profit of ¥208 million, ordinary profit of ¥130 million, interim net income attributable to owners of the parent of ¥69 million, and interim earnings per share of ¥2.65. Full year of the fiscal year ending March 2026: net sales of ¥23,917 million, operating profit of ¥574 million, ordinary profit of ¥534 million, net income attributable to owners of the parent of ¥263 million, and earnings per share of ¥9.99.
Reason for the revisionIn Japan, business opportunities in the artificial joint market declined, and there were instances in which the adoption of products was deferred. In the United States, transactions with some existing customers are expected to decline, along with the competitiveness of existing products, and the launch of new products is expected to be delayed. On the profit side, the company expects lower sales, a higher burden of fixed manufacturing costs accompanying lower production volumes, and higher import procurement costs due to the weaker yen. In addition, the forecast incorporates an adjustment to corporate income taxes of ¥629 million due to the reversal of deferred tax assets and one-time expenses of approximately ¥280 million, including retirement-related costs.
Details and amount of extraordinary lossAn adjustment to corporate income taxes of ¥629 million accompanying the reversal of deferred tax assets, and one-time expenses of approximately ¥280 million, including retirement-related costs.
Dividend forecast revisionThe dividend at the end of the second quarter remains ¥0, unchanged. The year-end dividend forecast was changed from ¥17 to ¥0, and the annual dividend forecast was changed from ¥17 to ¥0.
Consolidated / non-consolidatedConsolidated

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In Japan, net sales are expected to decline due to fewer business opportunities in the artificial joint market and decisions not to adopt products. In the United States, net sales are expected to decline due to reduced transactions with some existing customers, lower competitiveness of existing products, and delays in launching new products. Profit will be affected by lower sales, a higher burden of fixed manufacturing costs resulting from lower production volumes, higher import procurement costs due to the weaker yen, the recognition of an adjustment to corporate income taxes due to the reversal of deferred tax assets, and one-time expenses including retirement-related costs.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice concerning the difference between the forecast and actual consolidated results for the second quarter of the fiscal year ending March 2027, revisions to the full-year consolidated earnings forecast, recognition of adjustments to corporate income taxes and other items, and revisions to the dividend forecast | Japan Medical Dynamic Marketing,INC. (7600) timely disclosure | Komori